DSGN
Price
$10.27
Change
+$0.32 (+3.22%)
Updated
Feb 6 closing price
Capitalization
585.3M
37 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$10.60
Change
+$0.53 (+5.26%)
Updated
Feb 6 closing price
Capitalization
403.98M
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs TRDA

Header iconDSGN vs TRDA Comparison
Open Charts DSGN vs TRDABanner chart's image
Design Therapeutics
Price$10.27
Change+$0.32 (+3.22%)
Volume$246.78K
Capitalization585.3M
Entrada Therapeutics
Price$10.60
Change+$0.53 (+5.26%)
Volume$192.21K
Capitalization403.98M
DSGN vs TRDA Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. TRDA commentary
Feb 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 08, 2026
Stock price -- (DSGN: $10.27 vs. TRDA: $10.60)
Brand notoriety: DSGN and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 62% vs. TRDA: 89%
Market capitalization -- DSGN: $585.3M vs. TRDA: $403.98M
DSGN [@Biotechnology] is valued at $585.3M. TRDA’s [@Biotechnology] market capitalization is $403.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both DSGN and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 3 TA indicator(s) are bullish while TRDA’s TA Score has 3 bullish TA indicator(s).

  • DSGN’s TA Score: 3 bullish, 4 bearish.
  • TRDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than TRDA.

Price Growth

DSGN (@Biotechnology) experienced а +0.59% price change this week, while TRDA (@Biotechnology) price change was -7.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($585M) has a higher market cap than TRDA($404M). DSGN YTD gains are higher at: 9.488 vs. TRDA (3.113). DSGN has higher annual earnings (EBITDA): -77.38M vs. TRDA (-117.36M). TRDA has more cash in the bank: 327M vs. DSGN (206M). DSGN has less debt than TRDA: DSGN (1.74M) vs TRDA (52.4M). TRDA has higher revenues than DSGN: TRDA (61.5M) vs DSGN (0).
DSGNTRDADSGN / TRDA
Capitalization585M404M145%
EBITDA-77.38M-117.36M66%
Gain YTD9.4883.113305%
P/E RatioN/A10.26-
Revenue061.5M-
Total Cash206M327M63%
Total Debt1.74M52.4M3%
TECHNICAL ANALYSIS
Technical Analysis
DSGNTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
89%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISIIX15.010.33
+2.25%
Voya International Index Port S2
MRGBX40.280.82
+2.08%
MFS Core Equity B
EITGX60.580.91
+1.53%
Eaton Vance Tx-Mgd Growth 1.2 I
ALABX13.050.17
+1.32%
ALPS/Smith Balanced Opportunity A
IIGZX12.610.13
+1.04%
Voya Global High Dividend Low Vol Port I

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+3.22%
VRDN - DSGN
59%
Loosely correlated
+0.27%
IDYA - DSGN
59%
Loosely correlated
+1.26%
TRDA - DSGN
58%
Loosely correlated
+5.26%
SYRE - DSGN
57%
Loosely correlated
+6.62%
KRYS - DSGN
56%
Loosely correlated
+1.91%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been closely correlated with CGEM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRDA jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+5.26%
CGEM - TRDA
75%
Closely correlated
+3.21%
IPSC - TRDA
75%
Closely correlated
+1.80%
TERN - TRDA
74%
Closely correlated
+6.88%
STRO - TRDA
73%
Closely correlated
+6.30%
ATOS - TRDA
72%
Closely correlated
+0.19%
More